What is semaglutide? Learn how this GLP-1 receptor agonist works, its FDA-approved uses, side effects, and how quickly it may support weight loss.
Semaglutide is a prescription medication that mimics a hormone your body already makes called glucagon-like peptide-1 (GLP-1). It is FDA-approved to treat type 2 diabetes and, at a higher dose, for chronic weight management in adults who meet specific criteria. It is sold under brand names including Ozempic, Wegovy, and Rybelsus.
Doctors prescribe semaglutide as a once-weekly injection or a once-daily tablet. It is not a cure for diabetes or obesity, and it works best alongside nutrition changes, physical activity, and routine medical monitoring.
How Does Semaglutide Work? The MOA in Plain English
Semaglutide is a GLP-1 receptor agonist. That means it binds to the same receptors as the GLP-1 hormone your gut releases after a meal, but it stays active in the body far longer.
Once it binds, it triggers several effects at once:
- Appetite control: It acts on appetite centers in the brain, so you feel full sooner and stay full longer.
- Slower stomach emptying: Food leaves the stomach more gradually, which softens blood sugar spikes after meals.
- Better glucose control: It increases insulin release when blood sugar is high and reduces glucagon release.
This is the core of the semaglutide MOA that explains why one drug can affect both blood sugar and body weight. Because the molecule is long-acting, most injectable versions only need to be taken once a week.
FDA-Approved Uses and Available Forms
When people search for what is semaglutide used for, the answer depends on the product and the dose. The table below summarizes the main FDA-approved options.
| Product | Form | Schedule | Approved use |
|---|---|---|---|
| Ozempic | Injection pen | Once weekly | Type 2 diabetes; cardiovascular risk reduction in some patients |
| Wegovy | Injection pen | Once weekly | Chronic weight management; cardiovascular risk reduction |
| Rybelsus | Oral tablet | Once daily | Type 2 diabetes |
| Compounded semaglutide | Vial, pen, or drops | Varies | Not FDA-approved |
Injectable semaglutide is a clear, colorless liquid. That detail explains the frequent question of what color is semaglutide — if the solution in your pen looks cloudy, discolored, or contains particles, do not use it.
Compounded semaglutide is not reviewed by the FDA for safety, quality, or effectiveness, and its strength can vary between pharmacies. Ask your prescriber and pharmacist exactly what is in the vial before you use it.
Semaglutide Benefits Beyond Weight Loss
Large clinical trials have shown meaningful average weight loss over roughly 68 weeks with the weight-management dose, along with improved blood sugar control in people with type 2 diabetes.
- Average body weight reduction of about 15% in the STEP program trials.
- Lower A1C levels in patients with type 2 diabetes.
- Reduced risk of major cardiovascular events in adults with diabetes and existing heart disease.
- Possible improvements in blood pressure and liver fat markers, which are still being studied.
These are average results from research studies, not guaranteed outcomes. Individual responses vary widely, and the health benefits come from the medication combined with lasting lifestyle changes.
How Quickly Does Semaglutide Work?
Most people notice reduced appetite within the first week or two, but measurable weight change takes longer. The timeline below reflects typical prescribing patterns.
| Timeframe | What to expect |
|---|---|
| Weeks 1–4 | Appetite changes and possible nausea; the starting dose is kept low |
| Weeks 4–16 | Step-by-step dose increases; early weight loss usually appears |
| Months 3–6 | More consistent weight loss and improved blood sugar readings |
| Month 12 and beyond | Full effect at the maintenance dose; weight loss often plateaus |
Semaglutide is always started low and increased slowly. That ramp-up is deliberate: it gives your body time to adjust and lowers the chance of gastrointestinal side effects.
What Is Semaglutide Made Of?
Semaglutide is a synthetic peptide of 31 amino acids. It is a modified version of human GLP-1, built with two key changes that make it last much longer in the body.
- A fatty acid side chain that binds to albumin in the blood, slowing how fast the drug is cleared.
- Two amino acid substitutions that resist breakdown by the DPP-4 enzyme.
Semaglutide manufacturing relies on chemical peptide synthesis rather than extraction from plants or animals. There is no semaglutide in food, and no diet or supplement can replicate the drug's effect on GLP-1 receptors.
Semaglutide vs. Tirzepatide
Tirzepatide, sold as Mounjaro and Zepbound, targets two gut hormones instead of one. People asking what is the difference between semaglutide and tirzepatide compound are usually comparing a single-agonist with a dual-agonist, and that distinction matters for both results and side effects.
| Feature | Semaglutide | Tirzepatide |
|---|---|---|
| Receptor targets | GLP-1 | GIP and GLP-1 |
| Brand names | Ozempic, Wegovy, Rybelsus | Mounjaro, Zepbound |
| Average weight loss in trials | About 15% | About 20% |
| Schedule | Weekly injection or daily pill | Weekly injection |
| Common side effects | Nausea, vomiting, diarrhea, constipation | Similar gastrointestinal effects |
Head-to-head studies suggest tirzepatide may produce somewhat greater average weight loss, but both drugs are effective and share similar gastrointestinal side effects. The right choice depends on your health history and should be made with a prescriber.
Side Effects, Warnings, and Safety
Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. They often ease as your dose stabilizes, but they can be severe enough that some people stop treatment.
Semaglutide carries boxed warnings for thyroid C-cell tumors seen in rodents and for a risk of pancreatitis. It is not recommended for people with a personal or family history of medullary thyroid cancer or MEN2 syndrome.
Semaglutide is not recommended during pregnancy or breastfeeding, and it is a medical treatment rather than a cosmetic shortcut. Talk with a healthcare professional before starting, stopping, or changing your dose, and report severe abdominal pain, persistent vomiting, or signs of dehydration right away.
Semaglutide Is Not the Same as Research Peptides
Search results often blend prescription GLP-1 drugs with unapproved research chemicals sold online. Products described under terms like what is bpc 157 peptide are not FDA-approved drugs, are not interchangeable with semaglutide, and should not be self-administered based on a vendor's claims.
The same caution applies to other compounds marketed to consumers. If a website, forum post, or wiki page describes a homemade protocol, treat it as unverified. Reliable information comes from the FDA label, your prescriber, and your pharmacist.
Frequently Asked Questions
Is semaglutide the same as Ozempic?
Semaglutide is the active ingredient, and Ozempic is one brand name for it. Wegovy contains the same drug at a higher dose for weight management, while Rybelsus is the oral tablet form. They are not interchangeable without a prescriber's guidance, since the doses and approved uses differ.
How much weight can you lose on semaglutide?
In the STEP clinical trials, adults using the weight-management dose lost about 15% of their body weight on average over roughly 68 weeks, along with diet and exercise changes. Results vary widely between individuals. Weight often returns if the medication is stopped without sustained lifestyle changes.
Is semaglutide safe for long-term use?
Semaglutide has been studied in multi-year trials and is generally well tolerated, but it carries boxed warnings for thyroid C-cell tumors seen in rodents and for pancreatitis. Long-term use should be supervised by a healthcare professional who monitors your dose, side effects, and overall health.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.